Insight on Pharmaceuticals and Healthcare in Europe

Published within

« | 1 | 2 | 3 | » »|

Click here to sort results by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Report
Report

Stakeholder Opinions: Skin and Soft Tissue Infections - The end of the reign of vancomycin

This report gives a comprehensive overview of trends in epidemiology, diagnosis, treatment and referral patterns for skin and soft tissue infections (SSTIs). It discusses the challenges, opportunities and future developments for the SSTI drug market.

Published By Datamonitor
16 Jul 2009 $3800
Buy
Report
Report

Stakeholder Opinions: Therapeutic Vaccines - A far-off promise of greatness

This report assesses the current landscape of and future opportunities for therapeutic vaccines outside cancer, covering therapeutic vaccine approaches in cardiovascular and metabolic, CNS, autoimmune and infectious diseases.

Published By Datamonitor
17 Dec 2009 $3800
Buy
Report
Report

Stakeholder Opinions: Sexual Dysfunction - The quest for the new Viagra continues

Examination of the key issues in the treatment of sexual dysfunction, including risk factors, estimates of patient potential, overview of current and pipeline treatments, unmet needs, analysis of commercial opportunities and key stakeholder opinions.

Published By Datamonitor
04 Mar 2010 $7600
Buy
Report
Report

Italy Pharmaceutical Market Overview - Generic penetration set to rise

Overview of the Italian pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.

Published By Datamonitor
06 Jul 2010 $11400
Buy
Report
Report

Pipeline and Commercial Insight: Migraine - Challenges ahead for first-in-class developments

Analysis of the current and future migraine market. Includes sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.

Published By Datamonitor
13 Jul 2010 $15200
Buy
Report
Report

Pipeline and Commercial Insight: Allergic Rhinitis - Immunotherapy growth surpassed by generic erosion

Overview of the current and future allergic rhinitis market, including in-depth analysis of changes in the market, 10 year indication specific sales forecasts of key classes, and a 10 year interactive patient based forecast for immunotherapy.

Published By Datamonitor
14 Jul 2010 $15200
Buy
Report
Report

Pipeline and Commercial Insight: Insomnia - Future of innovative orexin drug class in doubt

Analysis of the current and future insomnia market. Includes sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.

Published By Datamonitor
14 Jul 2010 $15200
Buy
Report
Report

Pipeline and Commercial Insight: Moderate to Severe Chronic Nociceptive Pain - Anti-abuse opioids set to prosper

Analysis of the current and future moderate to severe chronic nociceptive pain market with sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key brands, generics, and pipeline products.

Published By Datamonitor
20 Aug 2010 $15200
Buy
Report
Report

Stakeholder Insight: Rheumatoid arthritis - Rising competition by line and severity

Datamonitor surveyed 183 rheumatologists in the seven major markets to gain insight into rheumatoid arthritis diagnosis, patient segmentation, current and future prescribing patterns, factors influencing decision making and key treatment challenges.

Published By Datamonitor
17 Sep 2010 $15200
Buy
Report
Report

Russia Pharmaceutical Market Overview - Pharma companies target Russia despite the challenges it presents

Overview of the Russian pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.

Published By Datamonitor
23 Nov 2010 $7600
Buy

« | 1 | 2 | 3 | » »|

No help is available.